10x Genomics to Participate in Upcoming June Investor Conferences

Rhea-AI Summary

10x Genomics (Nasdaq: TXG) announced its participation in two upcoming investor conferences. The William Blair 41st Annual Growth Stock Conference will feature a fireside chat on June 2, 2021, at 2:20 p.m. ET. Following this, the Goldman Sachs 42nd Annual Global Healthcare Conference will include a fireside chat on June 9, 2021, at 3:50 p.m. ET. Interested parties can access live and archived webcasts on the company's website.

10x Genomics specializes in life science technologies aimed at advancing human health, with a robust patent portfolio and significant global research adoption.

PLEASANTON, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating virtually in the following investor conferences:

• William Blair 41^st Annual Growth Stock Conference
  Fireside Chat on Wednesday, June 2^nd at 2:20 p.m. Eastern Time/11:20 p.m. Pacific Time

• Goldman Sachs 42^nd Annual Global Healthcare Conference
  Fireside Chat on Wednesday, June 9^th at 3:50 p.m. Eastern Time/12:50 p.m. Pacific Time
  

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.10xgenomics.com/.

About 10x Genomics
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2019 based on publications and all of the top 20 global pharmaceutical companies by 2019 research and development spend, and have been cited in over 2,500 research papers on discoveries ranging from oncology to immunology and neuroscience. The company’s patent portfolio comprises 1,100 issued patents and patent applications.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts
Media:
media@10xgenomics.com

Investors:
investors@10xgenomics.com

FAQ

What investor conferences is 10x Genomics participating in?

10x Genomics is participating in the William Blair 41st Annual Growth Stock Conference on June 2, 2021, and the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021.

Where can I watch the presentations by 10x Genomics?

You can access live and archived webcasts of 10x Genomics' presentations on their website's 'Investors' section.

What is the focus of 10x Genomics as a company?

10x Genomics focuses on life science technology, providing products to analyze biological systems to enhance human health.

How many patents does 10x Genomics hold?

10x Genomics has a patent portfolio comprising 1,100 issued patents and patent applications.

What type of research has 10x Genomics' products contributed to?

Products from 10x Genomics have been cited in over 2,500 research papers across various fields, including oncology, immunology, and neuroscience.